Study of Tislelizumab, Pamiparib, and Other Investigational Agents in Participants With Advanced Malignancies

NCT04164199 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

404

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Malignancies

Interventions

DRUG: Tislelizumab
DRUG: Pamiparib
DRUG: Temozolomide
DRUG: Sitravatinib
DRUG: Ociperlimab
DRUG: BAT1706
DRUG: Fruquintinib
DRUG: BGB-15025
DRUG: Zanidatamab
DRUG: BGB-A445
DRUG: Surzebiclimab
DRUG: Lenvatinib
DRUG: LBL-007

Sponsor

BeOne Medicines